veratrum viride root
Trade name: vertavis
Botanicalapproved
Approved
Jun 1, 1950
Clinical trial activity
0 trials · 0 clinical orgs · 2 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Timeline
1950s
- Jun 1, 1950
Irwin Neisler, & Company — Earliest FDA Approval
- Jun 1, 1950
Irwin Neisler, & Company — NDA Organization
Indications
Approved for
Mechanism of action
- Unspecified targetOTHER
Unknown
Hypotensive effect not fully understood
Approval history
- approvedJun 1, 1950
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Delivery
- Oral
- Availability
- Discontinued
Oral
Yes
Parenteral
No
Topical
No
Sources
- NCATS197B3Q7T5Q ↗
- ChEMBLCHEMBL1201531 ↗
Also known as
- veratrum
- veratrum
- veratrum
- veratrum viride
- veratrum viride root
- veratrum viride root
- veratrum viride root
- vertavis
- vertavis
Organizations
Marketing (2)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| Irwin Neisler, & Company | For profit | NDA | Jun 1, 1950 |
| Medpointe | For profit | NDA2 | — |